CERTICAN Side Effects

7023269-6 |
on May 20, 2010 Male patient from ITALY , weighting 165.3 lb, was diagnosed with heart transplant (What is heart transplant?) and was treated with Certican (View Usage). . Certican dosage: Unk. During the same period patient was treated with LESCOL LES+TAB (Unk) (View Lescol Les+tab Review and Lescol Les+tab Label ), NEORAL (Unk) (View Neoral Review and Neoral Label ), DELTACORTENE (Unk) (View Deltacortene Review and Deltacortene Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ).

7021108-0 | Blood Creatinine Increased, Proteinuria
Patient was taking Certican (View Usage). Patient had the following side effects: blood creatinine increased, proteinuria on Sep 22, 2010 from FRANCE Additional patient health information: Male patient , weighting 180.8 lb, was diagnosed with renal transplant, prophylaxis, hypertension and. Certican dosage: . During the same period patient was treated with NEORAL (275 Mg/day) (View Neoral Review and Neoral Label ), MYCOPHENOLIC ACID (1440 Mg/day) (View Mycophenolic Acid Review and Mycophenolic Acid Label ), BACTRIM (400 Mg) (View Bactrim Review and Bactrim Label ), VALACYCLOVIR HYDROCHLORIDE (3 Mg) (View Valacyclovir Hydrochloride Review and Valacyclovir Hydrochloride Label ), AMLODIPINE (10 Mg) (View Amlodipine Review and Amlodipine Label ), NEXIUM (20 Mg) (View Nexium Review and Nexium Label ), IRBESARTAN (300 Mg) (View Irbesartan Review and Irbesartan Label ), TAHOR (40 Mg) (View Tahor Review and Tahor Label ). Patient was hospitalized.

7019656-2 | Adrenalectomy, Concomitant Disease Progression, Endometrial Cancer Metastatic, Explorative Laparotomy, Hepatic Cancer Metastatic, Impaired Healing, Metastases To Adrenals, Metastases To Lung, Metastases To Peritoneum
Adverse event was reported on Sep 22, 2010 by a Female patient taking Certican (View Usage) (Dosage: 0.5 Mg, Bid) was diagnosed with liver transplant (What is liver transplant?) and. Location: CANADA , weighting 189.6 lb, After Certican was administered, patient had the following side effects: adrenalectomy, concomitant disease progression, endometrial cancer metastatic, explorative laparotomy, hepatic cancer metastatic, impaired healing, metastases to adrenals, metastases to lung, metastases to peritoneum. During the same period patient was treated with NEORAL (Unk) (View Neoral Review and Neoral Label ). Patient was hospitalized.

7014767-X | Endotracheal Intubation, Interstitial Lung Disease
on Sep 15, 2010 Female patient from BELGIUM , 55 years of age, was treated with Certican (View Usage). Patient experienced the following unwanted or unexpected effects: endotracheal intubation, interstitial lung disease. Certican dosage: . Patient was hospitalized.


7013332-8 | Abdominal Pain Upper, Blood Creatinine Increased, Blood Urea Increased, Blood Uric Acid Increased, C-reactive Protein Increased, Impaired Gastric Emptying, Nausea, Urinary Tract Infection
on Sep 16, 2010 Female patient from GERMANY , weighting 204.8 lb, was diagnosed with liver transplant (What is liver transplant?) and was treated with Certican (View Usage). Patient had the following side effects: abdominal pain upper, blood creatinine increased, blood urea increased, blood uric acid increased, c-reactive protein increased, impaired gastric emptying, nausea (What is nausea?), urinary tract infection (What is urinary tract infection?). Certican dosage: Unk. During the same period patient was treated with TACROLIMUS COMP TAC+ (Unk) (View Tacrolimus Comp-tac+ Review and Tacrolimus Comp-tac+ Label ). Patient was hospitalized.

7012979-2 | Bone Marrow Failure, Cough, Cytomegalovirus Test Positive, Headache, Hepatic Function Abnormal, Ovarian Cyst, Ovarian Enlargement, Ovarian Germ Cell Teratoma Benign, Pneumonia Cytomegaloviral
Patient was taking Certican (View Usage). After Certican was administered, patient had the following side effects: bone marrow failure, cough, cytomegalovirus test positive, headache (What is headache?), hepatic function abnormal, ovarian cyst (What is ovarian cyst?), ovarian enlargement, ovarian germ cell teratoma benign, pneumonia cytomegaloviral on Sep 16, 2010 from JAPAN Additional patient health information: Female patient , weighting 121.3 lb, was diagnosed with renal transplant, infection prophylaxis and. Certican dosage: 1.5 Mg / Day. During the same period patient was treated with SIMULECT (20 Mg (day 0)) (View Simulect Review and Simulect Label ), NEORAL (200 Mg / Day) (View Neoral Review and Neoral Label ), PREDNISOLONE (10 Mg / Day) (View Prednisolone Review and Prednisolone Label ), DENOSINE (250 Mg Daily) (View Denosine Review and Denosine Label ), BAKTAR (View Baktar Review and Baktar Label ), IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ). Patient was hospitalized.

7012011-0 | Blood Creatinine Increased, Cerebral Atrophy, Confusional State, Dehydration, Mental Status Changes, Renal Failure Acute
Adverse event was reported on Sep 16, 2010 by a Male patient taking Certican (View Usage) (Dosage: 1.5 Mg, Unk) was diagnosed with renal transplant and. Location: UNITED STATES , weighting 167.6 lb, Patient experienced the following unwanted or unexpected effects: blood creatinine increased, cerebral atrophy, confusional state, dehydration, mental status changes, renal failure acute. During the same period patient was treated with PROGRAF (Unk) (View Prograf Review and Prograf Label ), CYCLOSPORINE (Unk) (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

7009906-0 | Headache, Nausea, Nervous System Disorder
on Sep 22, 2010 Female patient from AUSTRALIA , weighting 121.3 lb, was diagnosed with lung transplant (What is lung transplant?) and was treated with Certican (View Usage). Patient had the following side effects: headache (What is headache?), nausea (What is nausea?), nervous system disorder. Certican dosage: 0.5mg/day. During the same period patient was treated with ERL 080A ERL+TAB (Unk) (View Erl 080a Erl+tab Review and Erl 080a Erl+tab Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

7009543-8 | Asthenia, Dyspepsia
on Sep 17, 2010 Male patient from ITALY , weighting 149.9 lb, was diagnosed with heart transplant (What is heart transplant?) and was treated with Certican (View Usage). After Certican was administered, patient had the following side effects: asthenia, dyspepsia. Certican dosage: 10mg/day. During the same period patient was treated with FLUVASTATIN G FLUV+XRTAB (40g/day) (View Fluvastatin G-fluv+xrtab Review and Fluvastatin G-fluv+xrtab Label ), NEORAL (175mg/day) (View Neoral Review and Neoral Label ), MYCOPHENOLATE MOFETIL (Unk) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

7008629-1 | Bacterial Infection, Colitis
Patient was taking Certican (View Usage). Patient experienced the following unwanted or unexpected effects: bacterial infection (What is bacterial infection?), colitis on Sep 16, 2010 from GERMANY Additional patient health information: Female patient , weighting 114.6 lb, was diagnosed with renal transplant and. Certican dosage: 1 Mg, Bid. During the same period patient was treated with MYFORTIC (360 Mg, Bid) (View Myfortic Review and Myfortic Label ), SANDIMMUNE (Unk) (View Sandimmune Review and Sandimmune Label ), URBASON (24 Mg / Day) (View Urbason Review and Urbason Label ). Patient was hospitalized.

7008624-2 | Lung Disorder
Adverse event was reported on Sep 15, 2010 by a Male patient taking Certican (View Usage) (Dosage: 0.75 Mg, Bid) was diagnosed with heart transplant (What is heart transplant?), polycythaemia and. Location: FRANCE , weighting 202.8 lb, Patient had the following side effects: lung disorder. During the same period patient was treated with MYCOPHENOLATE MOFETIL (250 Mg) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), TACROLIMUS (2.5 Mg, Bid) (View Tacrolimus Review and Tacrolimus Label ), EPOGEN (View Epogen Review and Epogen Label ). Patient was hospitalized.

7006676-7 | Abdominal Pain, Appendicectomy, Concomitant Disease Progression, Leukocytosis, Nephrectomy, Peritonitis, Pyrexia, Renal Cyst Ruptured
on Jun 03, 2010 Female patient from GERMANY , weighting 154.3 lb, was diagnosed with renal transplant and was treated with Certican (View Usage). After Certican was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), appendicectomy, concomitant disease progression, leukocytosis, nephrectomy, peritonitis, pyrexia, renal cyst ruptured. Certican dosage: 1.5 Mg/day. During the same period patient was treated with MYFORTIC (1080 Mg, Per Day) (View Myfortic Review and Myfortic Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), PANTOPRAZOLE SODIUM (40 Mg, Per Day) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), NORVASC (View Norvasc Review and Norvasc Label ), SUREM (View Surem Review and Surem Label ). Patient was hospitalized.

7004703-4 | Hyperthermia
on Sep 16, 2010 Female patient from CANADA , weighting 144.2 lb, was diagnosed with heart transplant (What is heart transplant?) and was treated with Certican (View Usage). Patient experienced the following unwanted or unexpected effects: hyperthermia. Certican dosage: 1.25 Mg Daily. During the same period patient was treated with NEORAL (View Neoral Review and Neoral Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ). Patient was hospitalized.

6997756-0 | Biliary Anastomosis Complication, Biliary Tract Disorder, Surgery
Patient was taking Certican (View Usage). Patient had the following side effects: biliary anastomosis complication, biliary tract disorder, surgery (What is surgery?) on Sep 10, 2010 from CZECH REPUBLIC Additional patient health information: Male patient , weighting 169.8 lb, was diagnosed with liver transplant (What is liver transplant?) and. Certican dosage: 2 Mg/24 Hr. During the same period patient was treated with TACROLIMUS COMP TAC+ (3 Mg/ 24 Hr) (View Tacrolimus Comp-tac+ Review and Tacrolimus Comp-tac+ Label ). Patient was hospitalized.

6997751-1 | Arthralgia
Adverse event was reported on Sep 10, 2010 by a Male patient taking Certican (View Usage) (Dosage: 1 Mg, Bid) was diagnosed with renal transplant and. Location: ITALY , weighting 163.1 lb, After Certican was administered, patient had the following side effects: arthralgia. During the same period patient was treated with NEORAL (100 Mg, Bid) (View Neoral Review and Neoral Label ). Patient was hospitalized.

6997750-X | Lymphocele, Lymphocele Marsupialisation
on Sep 10, 2010 Female patient from ITALY , weighting 88.18 lb, was diagnosed with renal transplant and was treated with Certican (View Usage). Patient experienced the following unwanted or unexpected effects: lymphocele, lymphocele marsupialisation. Certican dosage: 0.75 Mg, Bid. During the same period patient was treated with NEORAL (35 Mg, Bid) (View Neoral Review and Neoral Label ). Patient was hospitalized.

6997747-X | Pneumonia, Respiratory Tract Infection
on Sep 10, 2010 Male patient from AUSTRALIA , weighting 149.9 lb, was diagnosed with lung transplant (What is lung transplant?) and was treated with Certican (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?), respiratory tract infection. Certican dosage: 2 Mg. Patient was hospitalized.

6994322-8 | Skin Lesion, Skin Lesion Excision, Squamous Cell Carcinoma
Patient was taking Certican (View Usage). After Certican was administered, patient had the following side effects: skin lesion, skin lesion excision, squamous cell carcinoma on Sep 10, 2010 from AUSTRALIA Additional patient health information: Female patient , weighting 143.3 lb, was diagnosed with renal transplant and. Certican dosage: 2.25 Mg, Bid. During the same period patient was treated with MYFORTIC (720 Mg, Bid) (View Myfortic Review and Myfortic Label ), CYCLOSPORINE (Unk) (View Cyclosporine Review and Cyclosporine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6994320-4 | Headache, Nausea
Adverse event was reported on Sep 10, 2010 by a Female patient taking Certican (View Usage) (Dosage: 0.5mg/day) was diagnosed with lung transplant (What is lung transplant?) and. Location: AUSTRALIA , weighting 121.3 lb, Patient experienced the following unwanted or unexpected effects: headache (What is headache?), nausea (What is nausea?). Patient was hospitalized.

6991945-7 | Blood Alkaline Phosphatase Increased, Candidiasis, Gastrointestinal Infection, Hepatic Artery Stenosis, Hepatic Artery Thrombosis, Pyrexia, Sinusitis
on Sep 11, 2010 Male patient from ARGENTINA , weighting 163.1 lb, was diagnosed with liver transplant (What is liver transplant?), immunosuppression and was treated with Certican (View Usage). Patient had the following side effects: blood alkaline phosphatase increased, candidiasis, gastrointestinal infection, hepatic artery stenosis, hepatic artery thrombosis, pyrexia, sinusitis (What is sinusitis?). Certican dosage: Unk. During the same period patient was treated with TACROLIMUS COMP TAC+ (Unk) (View Tacrolimus Comp-tac+ Review and Tacrolimus Comp-tac+ Label ), DELTISONA (View Deltisona Review and Deltisona Label ). Patient was hospitalized.

6991688-X | Dyspnoea, Lung Disorder, Pulmonary Hypertension, Pulmonary Toxicity
on Sep 07, 2010 Female patient from UNITED STATES , weighting 219.8 lb, was diagnosed with renal transplant and was treated with Certican (View Usage). After Certican was administered, patient had the following side effects: dyspnoea, lung disorder, pulmonary hypertension (What is pulmonary hypertension?), pulmonary toxicity. Certican dosage: 3mg/day. Patient was hospitalized and became disabled.

6988709-7 | Acute Hepatic Failure, Ascites, Hepatitis B, Impaired Healing, Infection, Leukopenia, Liver Disorder
Patient was taking Certican (View Usage). Patient experienced the following unwanted or unexpected effects: acute hepatic failure, ascites, hepatitis b (What is hepatitis b?), impaired healing, infection (What is infection?), leukopenia, liver disorder on Sep 09, 2010 from GERMANY Additional patient health information: Male patient , weighting 189.6 lb, was diagnosed with liver transplant (What is liver transplant?) and. Certican dosage: 16 Mg, Daily. During the same period patient was treated with MYFORTIC (2160 Mg, Daily) (View Myfortic Review and Myfortic Label ), PREDNISOLON (View Prednisolon Review and Prednisolon Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), UDC (View Udc Review and Udc Label ), ZEFFIX (View Zeffix Review and Zeffix Label ), IRENAT (View Irenat Review and Irenat Label ), METHIMAZOLE (View Methimazole Review and Methimazole Label ). Patient was hospitalized.

6985903-6 | Pneumonia
Adverse event was reported on Sep 08, 2010 by a Female patient taking Certican (View Usage) (Dosage: Unk) was diagnosed with renal transplant and. Location: UNITED STATES , weighting 170.6 lb, Patient had the following side effects: pneumonia (What is pneumonia?). Patient was hospitalized.

6984345-7 | Blood Pressure Increased, Focal Segmental Glomerulosclerosis, Haematuria, Haemorrhage Urinary Tract, Post Procedural Complication, Proteinuria, Ureteric Obstruction, Urine Output Decreased
on Sep 09, 2010 Male patient from AUSTRALIA , weighting 175.8 lb, was diagnosed with renal transplant and was treated with Certican (View Usage). After Certican was administered, patient had the following side effects: blood pressure increased, focal segmental glomerulosclerosis, haematuria, haemorrhage urinary tract, post procedural complication, proteinuria, ureteric obstruction, urine output decreased. Certican dosage: 3 Mg, Daily. During the same period patient was treated with NEORAL (View Neoral Review and Neoral Label ), CLEXANE (View Clexane Review and Clexane Label ). Patient was hospitalized.

6980554-1 | Abdominal Pain Upper, Blood Creatinine Increased, Blood Urea Increased, Blood Uric Acid Increased, C-reactive Protein Increased, Impaired Gastric Emptying, Nausea, Urinary Tract Infection
on Sep 07, 2010 Female patient from GERMANY , weighting 204.8 lb, was diagnosed with liver transplant (What is liver transplant?) and was treated with Certican (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, blood creatinine increased, blood urea increased, blood uric acid increased, c-reactive protein increased, impaired gastric emptying, nausea (What is nausea?), urinary tract infection (What is urinary tract infection?). Certican dosage: Unk. During the same period patient was treated with TACROLIMUS COMP TAC+ (Unk) (View Tacrolimus Comp-tac+ Review and Tacrolimus Comp-tac+ Label ). Patient was hospitalized.

6979736-4 | Leukopenia, Neutropenia
Patient was taking Certican (View Usage). Patient had the following side effects: leukopenia, neutropenia on Sep 06, 2010 from FRANCE Additional patient health information: Male patient , weighting 156.5 lb, was diagnosed with renal transplant and. Certican dosage: 0.5 Mg, Bid. During the same period patient was treated with CELLCEPT (500 Mg) (View Cellcept Review and Cellcept Label ), MYCOPHENOLATE MOFETIL (Unk) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), SOLUPRED (View Solupred Review and Solupred Label ), MOPRAL (View Mopral Review and Mopral Label ), NEBIVOLOL HCL (View Nebivolol Hcl Review and Nebivolol Hcl Label ). Patient was hospitalized.

6979735-2 | Accidental Overdose, C-reactive Protein Increased, Diarrhoea, Pyrexia
Adverse event was reported on Sep 06, 2010 by a Male patient taking Certican (View Usage) (Dosage: 1.25 Mg, Bid) was diagnosed with renal transplant, hypocalcaemia, anaemia and. Location: FRANCE , weighting 156.5 lb, After Certican was administered, patient had the following side effects: accidental overdose, c-reactive protein increased, diarrhoea, pyrexia. During the same period patient was treated with NEORAL (View Neoral Review and Neoral Label ), CELLCEPT (1.5 G, Bid) (View Cellcept Review and Cellcept Label ), SOLUPRED (10 Mg / Day) (View Solupred Review and Solupred Label ), MOPRAL (View Mopral Review and Mopral Label ), PHOSPHORUS (View Phosphorus Review and Phosphorus Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ). Patient was hospitalized.

6979734-0 | Alveolitis, Cough, Endocarditis, Pneumonia, Pneumonitis, Pulmonary Fibrosis, Pulmonary Sepsis
on Sep 07, 2010 Female patient from GERMANY , weighting 169.8 lb, was diagnosed with renal transplant and was treated with Certican (View Usage). Patient experienced the following unwanted or unexpected effects: alveolitis, cough, endocarditis (What is endocarditis?), pneumonia (What is pneumonia?), pneumonitis, pulmonary fibrosis (What is pulmonary fibrosis?), pulmonary sepsis. Certican dosage: 2.5 Mg, Bid. During the same period patient was treated with MYFORTIC (Not Reported) (View Myfortic Review and Myfortic Label ), PROGRAF (Unk) (View Prograf Review and Prograf Label ), STEROIDS NOS (Unk) (View Steroids Nos Review and Steroids Nos Label ), CELLCEPT (2 G, Unk) (View Cellcept Review and Cellcept Label ). Patient was hospitalized.

6978359-0 | Cyst Drainage, Lymphocele
on Sep 08, 2010 Female patient from ITALY , weighting 133.4 lb, was treated with Certican (View Usage). Patient had the following side effects: cyst drainage, lymphocele. Certican dosage: 1.5 + 1.25. During the same period patient was treated with NEORAL (50 Unk, Bid) (View Neoral Review and Neoral Label ). Patient was hospitalized.

6977332-6 | Interstitial Lung Disease, Pneumonia, Pulmonary Embolism
Patient was taking Certican (View Usage). After Certican was administered, patient had the following side effects: interstitial lung disease, pneumonia (What is pneumonia?), pulmonary embolism (What is pulmonary embolism?) on Sep 01, 2010 from UNITED STATES Additional patient health information: Male patient , 67 years of age, weighting 227.1 lb, was diagnosed with renal transplant and. Certican dosage: 0.75 Mg, Bid. Patient was hospitalized.

6974353-4 | Cough, Dyspnoea, Pneumonia, Pyrexia
Adverse event was reported on Sep 01, 2010 by a Female patient taking Certican (View Usage) (Dosage: 2 Mg, Bid) was diagnosed with liver transplant (What is liver transplant?) and. Location: SPAIN , weighting 134.5 lb, Patient experienced the following unwanted or unexpected effects: cough, dyspnoea, pneumonia (What is pneumonia?), pyrexia. During the same period patient was treated with TACROLIMUS COMP TAC+ (1.5 Mg, Qd) (View Tacrolimus Comp-tac+ Review and Tacrolimus Comp-tac+ Label ), TACROLIMUS COMP TAC+ (0.5 Mg, Q12h) (View Tacrolimus Comp-tac+ Review and Tacrolimus Comp-tac+ Label ). Patient was hospitalized.

6974274-7 | Biliary Anastomosis Complication, Biliary Tract Disorder, Surgery
on Jul 13, 2010 Male patient from CZECH REPUBLIC , weighting 169.8 lb, was diagnosed with liver transplant (What is liver transplant?) and was treated with Certican (View Usage). Patient had the following side effects: biliary anastomosis complication, biliary tract disorder, surgery (What is surgery?). Certican dosage: 2 Mg/24 Hr. During the same period patient was treated with TACROLIMUS COMP TAC+ (3 Mg/ 24 Hr) (View Tacrolimus Comp-tac+ Review and Tacrolimus Comp-tac+ Label ). Patient was hospitalized.

6971668-0 | Blood Creatinine Increased, Glomerulonephritis Proliferative
on Sep 02, 2010 Male patient from GERMANY , weighting 166.4 lb, was diagnosed with renal transplant and was treated with Certican (View Usage). After Certican was administered, patient had the following side effects: blood creatinine increased, glomerulonephritis proliferative. Certican dosage: 2-3 Mg / Day. During the same period patient was treated with SANDIMMUNE (200mg/day) (View Sandimmune Review and Sandimmune Label ), MYFORTIC (720-1440 Mg / Day) (View Myfortic Review and Myfortic Label ). Patient was hospitalized.

6968777-9 | Bacterial Infection, Colitis
Patient was taking Certican (View Usage). Patient experienced the following unwanted or unexpected effects: bacterial infection (What is bacterial infection?), colitis on Sep 01, 2010 from GERMANY Additional patient health information: Female patient , weighting 114.6 lb, was diagnosed with renal transplant and. Certican dosage: 1 Mg, Bid. During the same period patient was treated with MYFORTIC (360 Mg, Bid) (View Myfortic Review and Myfortic Label ), URBASON (24 Mg / Day) (View Urbason Review and Urbason Label ). Patient was hospitalized.

6968554-9 | Azotaemia, Complications Of Transplanted Kidney, Nephropathy Toxic, Renal Tubular Necrosis
Adverse event was reported on Sep 06, 2010 by a Male patient taking Certican (View Usage) (Dosage: 2.25 Mg, Unk) was diagnosed with renal transplant and. Location: ITALY , weighting 209.4 lb, Patient had the following side effects: azotaemia, complications of transplanted kidney, nephropathy toxic, renal tubular necrosis. During the same period patient was treated with NEORAL (50 Mg, Unk) (View Neoral Review and Neoral Label ), DELTACORTENE (7.5 Mg, Unk) (View Deltacortene Review and Deltacortene Label ). Patient was hospitalized.

6968480-5 | Cyst Drainage, Lymphocele
on Aug 31, 2010 Female patient from ITALY , weighting 133.4 lb, was treated with Certican (View Usage). After Certican was administered, patient had the following side effects: cyst drainage, lymphocele. Certican dosage: 1.5 + 1.25. During the same period patient was treated with NEORAL (50 Unk, Bid) (View Neoral Review and Neoral Label ). Patient was hospitalized.

6968476-3 | Abdominal Pain Upper, Blood Creatinine Increased, Blood Urea Increased, Blood Uric Acid Increased, C-reactive Protein Increased, Impaired Gastric Emptying, Nausea, Urinary Tract Infection
on Aug 31, 2010 Female patient from GERMANY , weighting 204.8 lb, was diagnosed with liver transplant (What is liver transplant?) and was treated with Certican (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, blood creatinine increased, blood urea increased, blood uric acid increased, c-reactive protein increased, impaired gastric emptying, nausea (What is nausea?), urinary tract infection (What is urinary tract infection?). Certican dosage: Unk. During the same period patient was treated with TACROLIMUS COMP TAC+ (Unk) (View Tacrolimus Comp-tac+ Review and Tacrolimus Comp-tac+ Label ). Patient was hospitalized.

6966832-0 | Pneumonia
Patient was taking Certican (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?) on Aug 24, 2010 from AUSTRALIA Additional patient health information: Male patient , weighting 149.9 lb, was diagnosed with lung transplant (What is lung transplant?) and. Certican dosage: 2 Mg. Patient was hospitalized.

6966288-8 | Nephritis, Proteinuria
Adverse event was reported on Aug 24, 2010 by a Male patient taking Certican (View Usage) (Dosage: 1.5 Mg, Bid) was diagnosed with kidney transplant rejection and. Location: MALAYSIA , 23 years of age, weighting 88.18 lb, After Certican was administered, patient had the following side effects: nephritis, proteinuria. Patient was hospitalized.

6965243-1 | Erythema, Pruritus, Toxic Skin Eruption
on Aug 30, 2010 Male patient from NETHERLANDS , weighting 220.5 lb, was diagnosed with liver transplant (What is liver transplant?) and was treated with Certican (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, pruritus, toxic skin eruption. Certican dosage: 2 Mg, Bid. During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), NEORAL (100 Mg, Bid) (View Neoral Review and Neoral Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ). Patient was hospitalized.

6963868-0 | Blood Lactate Dehydrogenase Increased, Haemolytic Anaemia, Marrow Hyperplasia
on Aug 30, 2010 Male patient from UNITED STATES , weighting 256.4 lb, was diagnosed with renal transplant and was treated with Certican (View Usage). Patient had the following side effects: blood lactate dehydrogenase increased, haemolytic anaemia, marrow hyperplasia. Certican dosage: 1.5 Mg Bid. Patient was hospitalized.

6961750-6 | Blood Creatinine Increased, Lymphocele, Oedema Peripheral
Patient was taking Certican (View Usage). After Certican was administered, patient had the following side effects: blood creatinine increased, lymphocele, oedema peripheral on Aug 24, 2010 from GERMANY Additional patient health information: Male patient , weighting 198.4 lb, was diagnosed with renal transplant and. Certican dosage: Unk. During the same period patient was treated with NEORAL (View Neoral Review and Neoral Label ). Patient was hospitalized.

6961633-1 | Blood Creatinine Increased, Kidney Transplant Rejection
Adverse event was reported on Aug 24, 2010 by a Male patient taking Certican (View Usage) (Dosage: 2.5 Mg, Bid) was diagnosed with renal transplant and. Location: GERMANY , weighting 196.2 lb, Patient experienced the following unwanted or unexpected effects: blood creatinine increased, kidney transplant rejection. During the same period patient was treated with MYFORTIC (720 Mg, Bid) (View Myfortic Review and Myfortic Label ), URBASON (40 Mg, Qd) (View Urbason Review and Urbason Label ). Patient was hospitalized.

6961624-0 | Confusional State, Mental Status Changes, Reversible Posterior Leukoencephalopathy Syndrome
on Aug 23, 2010 Male patient from UNITED STATES , weighting 167.6 lb, was diagnosed with renal transplant and was treated with Certican (View Usage). Patient had the following side effects: confusional state, mental status changes, reversible posterior leukoencephalopathy syndrome. Certican dosage: 1.5 Mg, Unk. During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ). Patient was hospitalized.

6958826-6 | Bronchopneumonia, Hepatic Artery Thrombosis, Klebsiella Infection, Pyrexia, Septic Shock, Thrombocytopenia
on Aug 26, 2010 Male patient from BRAZIL , weighting 170.0 lb, was diagnosed with liver transplant (What is liver transplant?) and was treated with Certican (View Usage). After Certican was administered, patient had the following side effects: bronchopneumonia, hepatic artery thrombosis, klebsiella infection, pyrexia, septic shock, thrombocytopenia. Certican dosage: 1mg/day. During the same period patient was treated with TACROLIMUS COMP TAC+ (8mg + 9mg/day) (View Tacrolimus Comp-tac+ Review and Tacrolimus Comp-tac+ Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.

6957395-4 | Alcoholism, Diffuse Alveolar Damage, Hepatic Artery Thrombosis, Hepatic Cirrhosis, Post Procedural Complication
Patient was taking Certican (View Usage). Patient experienced the following unwanted or unexpected effects: alcoholism (What is alcoholism?), diffuse alveolar damage, hepatic artery thrombosis, hepatic cirrhosis, post procedural complication on Aug 26, 2010 from BRAZIL Additional patient health information: Male patient , weighting 244.7 lb, was diagnosed with liver transplant (What is liver transplant?) and. Certican dosage: 2mg/day.

6946175-1 | Complications Of Transplanted Kidney, Nephropathy Toxic, Renal Tubular Necrosis
Adverse event was reported on Aug 20, 2010 by a Male patient taking Certican (View Usage) (Dosage: 2.25 Mg, Unk) was diagnosed with renal transplant and. Location: ITALY , weighting 209.4 lb, Patient had the following side effects: complications of transplanted kidney, nephropathy toxic, renal tubular necrosis. During the same period patient was treated with NEORAL (50 Mg, Unk) (View Neoral Review and Neoral Label ), DELTACORTENE (7.5 Mg, Unk) (View Deltacortene Review and Deltacortene Label ). Patient was hospitalized.

6946172-6 | Asthenia, Dyspepsia
on Aug 20, 2010 Male patient from ITALY , weighting 149.9 lb, was diagnosed with heart transplant (What is heart transplant?) and was treated with Certican (View Usage). After Certican was administered, patient had the following side effects: asthenia, dyspepsia. Certican dosage: 10mg/day. During the same period patient was treated with NEORAL (175mg/day) (View Neoral Review and Neoral Label ), FLUVASTATIN G FLUV+XRTAB (40g/day) (View Fluvastatin G-fluv+xrtab Review and Fluvastatin G-fluv+xrtab Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6946164-7 | Anaphylactic Reaction, Eosinophilia, Hepatitis, Tubulointerstitial Nephritis
on Aug 16, 2010 Male patient from SPAIN , 46 years of age, was diagnosed with renal transplant, anaemia and was treated with Certican (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, eosinophilia, hepatitis (What is hepatitis?), tubulointerstitial nephritis. Certican dosage: 4 Mg, Bid. During the same period patient was treated with ARANESP (View Aranesp Review and Aranesp Label ), CELLCEPT (1 G, Bid) (View Cellcept Review and Cellcept Label ), FERRO SANOL (Unk) (View Ferro Sanol Review and Ferro Sanol Label ), PROGRAF (2 Mg, Bid) (View Prograf Review and Prograf Label ). Patient was hospitalized.

6943636-6 | Confusional State, Mental Status Changes, Reversible Posterior Leukoencephalopathy Syndrome
Patient was taking Certican (View Usage). Patient had the following side effects: confusional state, mental status changes, reversible posterior leukoencephalopathy syndrome on Aug 19, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 167.6 lb, was diagnosed with renal transplant and. Certican dosage: 1.5 Mg, Unk. During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ). Patient was hospitalized.